Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAFF: Rosuvastatin in Hip Fracture
NCT01494090Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Aug 2011
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in hip fracture, sponsored by Centre Hospitalier Universitaire de Brest. Started Aug 2011; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT01494090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494090.